BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Report Library

All Reports
Datamonitor Healthcare Infectious Diseases: Hepatitis B Market Spotlight

February 15, 2019

Hepatitis B is a liver disease caused by chronic infection with hepatitis B virus (HBV). Chronic HBV infection is a major cause of cirrhosis, liver failure, and hepatocellular carcinoma (HCC), and is estimated to have caused 887,000 deaths in 2015. In chronic hepatitis B (CHB) cases, 20– 30% of patients develop cirrhosis and HCC as complications. Acute HBV infections are usually asymptomatic, and only 30–50% of individuals aged five years or above display signs and symptoms. If present, symptoms include nausea, vomiting, fever, loss of appetite, fatigue, clay- colored bowel movements, dark urine, abdominal pain, joint pain, and jaundice. Acute infection very rarely leads to fulminant hepatitis. The majority of individuals with chronic infection are asymptomatic and have no apparent signs of liver disease, while in some people it progresses to chronic hepatitis, cirrhosis, or HCC.

This Datamonitor Healthcare report contains a Market Spotlight module.
Indications Covered: Hepatitis B (HBV) Treatment (Antiviral)
Back to the top Back to the top